News

Coherus BioSciences Appoints Charlie Newton to Board of Directors

- Biotechnology Chief Financial Officer and highly regarded former healthcare investment banker brings decades of industry experience to Coherus’ immuno-oncology…

2 years ago

Smart for Life Names Darren C. Minton Chief Executive Officer

Mr. Minton Has Served as President Since 2017 Darren C. Minton Chief Executive OfficerMIAMI, May 05, 2022 (GLOBE NEWSWIRE) --…

2 years ago

Palisade Bio and Newsoara Receive NMPA Clearance to Commence Phase 3 Clinical Trial in China Evaluating LB1148 to Accelerate the Return of Bowel Function Following Abdominal Surgery

NMPA clearance expands global Phase 3 clinical development program; Company recently announced clearance from U.S. Food and Drug Administration to…

2 years ago

Biofrontera Inc. to Showcase Actinic Keratosis Treatments at the Music City Symposium for Cosmetic Advances & Laser Education

Live Demonstration of New RhodoLED® XL to be Featured WOBURN, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq:…

2 years ago

Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of Directors

Raphael (“Rafi”) Hofstein, Ph.D. Brings Invaluable Experience to Scopus BioPharmaNEW YORK, May 05, 2022 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc.…

2 years ago

EDAP to Showcase its Focal One® Platform at the Annual Meeting of the American Urological Association (AUA)

  AUA is the largest annual gathering of urologists worldwide LYON, France, May 5, 2022 -- EDAP TMS SA (Nasdaq:…

2 years ago

ABVC BioPharma Announces Streamlined Vitargus® Manufacturing Process

New Process Improves Quality and Lowers Cost Fremont, CA, May 05, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ:ABVC), a…

2 years ago

Wave Life Sciences to Webcast Conference Call of First Quarter 2022 Financial Results on May 12, 2022

CAMBRIDGE, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed…

2 years ago

Odyssey Health, Inc. Announces Positive Results from Initial Phase I Clinical Trial Subjects for Concussion Drug

Irvine, CA, May 05, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, Inc., a…

2 years ago

SCYNEXIS to Report First Quarter 2022 Financial Results and Provide a Corporate Update on May 12

JERSEY CITY, N.J., May 05, 2022 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to…

2 years ago